Educational Efforts Are First Front Of Marketing Battle For PCSK9s
Executive Summary
With reams of PCSK9 data showing robust lowering of LDL – a trusted surrogate – under their belt, sponsors aim to win over prescribers, payers and patients ahead of outcomes trial releases.